During the past decade, El Camino Hospital Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 25 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "El Camino Hospital Cancer Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 12 trials, followed by "SWOG Cancer Research Network" with 10 trials sponsored, "NSABP Foundation Inc" with 3 trials sponsored, "Radiation Therapy Oncology Group" with 2 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "El Camino Hospital Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 29 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator, "Novartis" with 2 trials as a collaborator and "SWOG Cancer Research Network" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "El Camino Hospital Cancer Center" are "Breast Cancer" (13 trials), "Lung Cancer" (7 trials), "Prostate Cancer" (5 trials), "Colorectal Cancer" (3 trials) and "Metastatic Cancer" (3 trials). Many other conditions were trialed in "El Camino Hospital Cancer Center" in a lesser frequency.

Most popular intervention types in "El Camino Hospital Cancer Center" are "Drug" (19 trials), "Other" (13 trials), "Biological" (6 trials), "Radiation" (5 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (8 trials), "bevacizumab" (4 trials), "carboplatin" (3 trials), "cyclophosphamide" (3 trials) and "docetaxel" (3 trials). Other intervention names were less common.

The vast majority of trials in "El Camino Hospital Cancer Center" are 17 trials for "All" genders, 9 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "El Camino Hospital Cancer Center". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in El Camino Hospital Cancer Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in El Camino Hospital Cancer Center, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".